Filing Details
- Accession Number:
- 0001567619-18-001420
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2018-08-17 20:17:46
- Reporting Period:
- 2018-08-17
- Accepted Time:
- 2018-08-17 20:17:46
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 1594337 | Corium International Inc. | CORI | Pharmaceutical Preparations (2834) | 383230774 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1603700 | Parminder Singh | C/O Corium International, Inc. 235 Constituion Drive Menlo Park CA 94025 | Cto & Vice President, R&D | No | Yes | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Acquisiton | 2018-08-17 | 2,813 | $0.00 | 12,753 | No | 4 | M | Direct | |
| Common Stock | Acquisiton | 2018-08-17 | 6,250 | $0.00 | 19,003 | No | 4 | M | Direct | |
| Common Stock | Disposition | 2018-08-17 | 3,133 | $9.01 | 15,870 | No | 4 | S | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | M | Direct | |
| No | 4 | M | Direct | |
| No | 4 | S | Direct |
Reported Derivative Transactions
| Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
|---|---|---|---|---|---|---|---|
| Common Stock | Restricted Stock Units (RSU) | Disposition | 2018-08-17 | 2,813 | $0.00 | 2,813 | $0.00 |
| Common Stock | Restricted Stock Units (RSU) | Disposition | 2018-08-17 | 6,250 | $0.00 | 6,250 | $0.00 |
| Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
|---|---|---|---|---|---|---|
| 8,437 | No | 4 | M | Direct | ||
| 6,250 | No | 4 | M | Direct |
Footnotes
- Includes 1,000 shares acquired under the Issuer's employee stock purchase plan on May 18, 2018.
- Represents the number of shares required to be sold by the reporting person to cover tax withholding obligations in connection with the vesting of the Restricted Stock Units ("RSUs") listed in Table II. This sale is mandated by the Issuer's election under its equity incentive plans to require the satisfaction of tax withholding obligations to be funded by a "sell to cover" transaction and does not represent a discretionary trade by the reporting person.
- The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $8.59 to $9.16 per share, inclusive. The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon written request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
- Each RSU represents the contingent right to receive one share of the issuer's common stock upon settlement.
- The RSUs vest as to 1/4 of the total number of shares on January 4, 2018 and then 1/4 of the total number of shares on January 4 of each successive year thereafter, subject to the Issuer's Insider Trading Policy and trading window and to the reporting person's continued service with the Issuer through each vesting date.
- The RSUs vest as to 50% of the total number of shares on July 12, 2018 and the remaining 50% of the total number of shares on July 12, 2019, subject to the Issuer's Insider Trading Policy and trading window and to the reporting person's continued service with the Issuer through each vesting date.
Billionaire Hedge Funds
